The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Biological Therapy Market 2025 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Cancer Biological Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Biological Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Cancer Biological Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal Antibodies segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Cancer Biological Therapy include ELI Lilly, Sanofi, Merck, Bayer, and Roche, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Biological Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Vaccines
Cancer Growth Blockers
Blood Cell Growth Factors
Market segment by Application, can be divided into
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Market segment by players, this report covers
ELI Lilly
Sanofi
Merck
Bayer
Roche
Novartis International
Pfizer
Bristol-Myers Squibb
Seattle Genetics
Amgen
Takeda Pharmaceuticals
GlaxoSmithKline
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.
Otsuka
Eisai
Abbvie
Incyte
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cancer Biological Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cancer Biological Therapy, with revenue, gross margin and global market share of Cancer Biological Therapy from 2019 to 2022.
Chapter 3, the Cancer Biological Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Biological Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Cancer Biological Therapy research findings and conclusion, appendix and data source.
Geographical Area
Global
The Cancer Biological Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Biological Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Cancer Biological Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal Antibodies segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Cancer Biological Therapy include ELI Lilly, Sanofi, Merck, Bayer, and Roche, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cancer Biological Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Vaccines
Cancer Growth Blockers
Blood Cell Growth Factors
Market segment by Application, can be divided into
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Market segment by players, this report covers
ELI Lilly
Sanofi
Merck
Bayer
Roche
Novartis International
Pfizer
Bristol-Myers Squibb
Seattle Genetics
Amgen
Takeda Pharmaceuticals
GlaxoSmithKline
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.
Otsuka
Eisai
Abbvie
Incyte
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cancer Biological Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cancer Biological Therapy, with revenue, gross margin and global market share of Cancer Biological Therapy from 2019 to 2022.
Chapter 3, the Cancer Biological Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Biological Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Cancer Biological Therapy research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Cancer Biological Therapy
1.2 Classification of Cancer Biological Therapy by Type
1.2.1 Overview: Global Cancer Biological Therapy Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Cancer Biological Therapy Revenue Market Share by Type in 2021
1.2.3 Monoclonal Antibodies
1.2.4 Vaccines
1.2.5 Cancer Growth Blockers
1.2.6 Blood Cell Growth Factors
1.3 Global Cancer Biological Therapy Market by Application
1.3.1 Overview: Global Cancer Biological Therapy Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research & Academic Laboratories
1.3.5 Pharmaceutical & Biotechnology Companies
1.4 Global Cancer Biological Therapy Market Size & Forecast
1.5 Global Cancer Biological Therapy Market Size and Forecast by Region
1.5.1 Global Cancer Biological Therapy Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Cancer Biological Therapy Market Size by Region, (2017-2022)
1.5.3 North America Cancer Biological Therapy Market Size and Prospect (2017-2028)
1.5.4 Europe Cancer Biological Therapy Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Cancer Biological Therapy Market Size and Prospect (2017-2028)
1.5.6 South America Cancer Biological Therapy Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Cancer Biological Therapy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Biological Therapy Market Drivers
1.6.2 Cancer Biological Therapy Market Restraints
1.6.3 Cancer Biological Therapy Trends Analysis
2 Company Profiles
2.1 ELI Lilly
2.1.1 ELI Lilly Details
2.1.2 ELI Lilly Major Business
2.1.3 ELI Lilly Cancer Biological Therapy Product and Solutions
2.1.4 ELI Lilly Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 ELI Lilly Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Cancer Biological Therapy Product and Solutions
2.2.4 Sanofi Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Cancer Biological Therapy Product and Solutions
2.3.4 Merck Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Merck Recent Developments and Future Plans
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Cancer Biological Therapy Product and Solutions
2.4.4 Bayer Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Bayer Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Cancer Biological Therapy Product and Solutions
2.5.4 Roche Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Roche Recent Developments and Future Plans
2.6 Novartis International
2.6.1 Novartis International Details
2.6.2 Novartis International Major Business
2.6.3 Novartis International Cancer Biological Therapy Product and Solutions
2.6.4 Novartis International Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Novartis International Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Cancer Biological Therapy Product and Solutions
2.7.4 Pfizer Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Cancer Biological Therapy Product and Solutions
2.8.4 Bristol-Myers Squibb Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.9 Seattle Genetics
2.9.1 Seattle Genetics Details
2.9.2 Seattle Genetics Major Business
2.9.3 Seattle Genetics Cancer Biological Therapy Product and Solutions
2.9.4 Seattle Genetics Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Seattle Genetics Recent Developments and Future Plans
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Cancer Biological Therapy Product and Solutions
2.10.4 Amgen Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Amgen Recent Developments and Future Plans
2.11 Takeda Pharmaceuticals
2.11.1 Takeda Pharmaceuticals Details
2.11.2 Takeda Pharmaceuticals Major Business
2.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Product and Solutions
2.11.4 Takeda Pharmaceuticals Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Takeda Pharmaceuticals Recent Developments and Future Plans
2.12 GlaxoSmithKline
2.12.1 GlaxoSmithKline Details
2.12.2 GlaxoSmithKline Major Business
2.12.3 GlaxoSmithKline Cancer Biological Therapy Product and Solutions
2.12.4 GlaxoSmithKline Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 GlaxoSmithKline Recent Developments and Future Plans
2.13 Spectrum Pharmaceuticals
2.13.1 Spectrum Pharmaceuticals Details
2.13.2 Spectrum Pharmaceuticals Major Business
2.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Product and Solutions
2.13.4 Spectrum Pharmaceuticals Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
2.14 Celgene Corporation
2.14.1 Celgene Corporation Details
2.14.2 Celgene Corporation Major Business
2.14.3 Celgene Corporation Cancer Biological Therapy Product and Solutions
2.14.4 Celgene Corporation Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Celgene Corporation Recent Developments and Future Plans
2.15 AstraZeneca, Plc.
2.15.1 AstraZeneca, Plc. Details
2.15.2 AstraZeneca, Plc. Major Business
2.15.3 AstraZeneca, Plc. Cancer Biological Therapy Product and Solutions
2.15.4 AstraZeneca, Plc. Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 AstraZeneca, Plc. Recent Developments and Future Plans
2.16 Otsuka
2.16.1 Otsuka Details
2.16.2 Otsuka Major Business
2.16.3 Otsuka Cancer Biological Therapy Product and Solutions
2.16.4 Otsuka Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Otsuka Recent Developments and Future Plans
2.17 Eisai
2.17.1 Eisai Details
2.17.2 Eisai Major Business
2.17.3 Eisai Cancer Biological Therapy Product and Solutions
2.17.4 Eisai Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Eisai Recent Developments and Future Plans
2.18 Abbvie
2.18.1 Abbvie Details
2.18.2 Abbvie Major Business
2.18.3 Abbvie Cancer Biological Therapy Product and Solutions
2.18.4 Abbvie Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Abbvie Recent Developments and Future Plans
2.19 Incyte
2.19.1 Incyte Details
2.19.2 Incyte Major Business
2.19.3 Incyte Cancer Biological Therapy Product and Solutions
2.19.4 Incyte Cancer Biological Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Incyte Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cancer Biological Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Cancer Biological Therapy Players Market Share in 2021
3.2.2 Top 10 Cancer Biological Therapy Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Cancer Biological Therapy Players Head Office, Products and Services Provided
3.4 Cancer Biological Therapy Mergers & Acquisitions
3.5 Cancer Biological Therapy New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cancer Biological Therapy Revenue and Market Share by Type (2017-2022)
4.2 Global Cancer Biological Therapy Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Cancer Biological Therapy Revenue Market Share by Application (2017-2022)
5.2 Global Cancer Biological Therapy Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Cancer Biological Therapy Revenue by Type (2017-2028)
6.2 North America Cancer Biological Therapy Revenue by Application (2017-2028)
6.3 North America Cancer Biological Therapy Market Size by Country
6.3.1 North America Cancer Biological Therapy Revenue by Country (2017-2028)
6.3.2 United States Cancer Biological Therapy Market Size and Forecast (2017-2028)
6.3.3 Canada Cancer Biological Therapy Market Size and Forecast (2017-2028)
6.3.4 Mexico Cancer Biological Therapy Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Cancer Biological Therapy Revenue by Type (2017-2028)
7.2 Europe Cancer Biological Therapy Revenue by Application (2017-2028)
7.3 Europe Cancer Biological Therapy Market Size by Country
7.3.1 Europe Cancer Biological Therapy Revenue by Country (2017-2028)
7.3.2 Germany Cancer Biological Therapy Market Size and Forecast (2017-2028)
7.3.3 France Cancer Biological Therapy Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Cancer Biological Therapy Market Size and Forecast (2017-2028)
7.3.5 Russia Cancer Biological Therapy Market Size and Forecast (2017-2028)
7.3.6 Italy Cancer Biological Therapy Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cancer Biological Therapy Revenue by Type (2017-2028)
8.2 Asia-Pacific Cancer Biological Therapy Revenue by Application (2017-2028)
8.3 Asia-Pacific Cancer Biological Therapy Market Size by Region
8.3.1 Asia-Pacific Cancer Biological Therapy Revenue by Region (2017-2028)
8.3.2 China Cancer Biological Therapy Market Size and Forecast (2017-2028)
8.3.3 Japan Cancer Biological Therapy Market Size and Forecast (2017-2028)
8.3.4 South Korea Cancer Biological Therapy Market Size and Forecast (2017-2028)
8.3.5 India Cancer Biological Therapy Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Cancer Biological Therapy Market Size and Forecast (2017-2028)
8.3.7 Australia Cancer Biological Therapy Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Cancer Biological Therapy Revenue by Type (2017-2028)
9.2 South America Cancer Biological Therapy Revenue by Application (2017-2028)
9.3 South America Cancer Biological Therapy Market Size by Country
9.3.1 South America Cancer Biological Therapy Revenue by Country (2017-2028)
9.3.2 Brazil Cancer Biological Therapy Market Size and Forecast (2017-2028)
9.3.3 Argentina Cancer Biological Therapy Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cancer Biological Therapy Revenue by Type (2017-2028)
10.2 Middle East & Africa Cancer Biological Therapy Revenue by Application (2017-2028)
10.3 Middle East & Africa Cancer Biological Therapy Market Size by Country
10.3.1 Middle East & Africa Cancer Biological Therapy Revenue by Country (2017-2028)
10.3.2 Turkey Cancer Biological Therapy Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Cancer Biological Therapy Market Size and Forecast (2017-2028)
10.3.4 UAE Cancer Biological Therapy Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Cancer Biological Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Cancer Biological Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Cancer Biological Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Cancer Biological Therapy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Cancer Biological Therapy Revenue Market Share by Region (2023-2028)
Table 6. ELI Lilly Corporate Information, Head Office, and Major Competitors
Table 7. ELI Lilly Major Business
Table 8. ELI Lilly Cancer Biological Therapy Product and Solutions
Table 9. ELI Lilly Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Sanofi Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Cancer Biological Therapy Product and Solutions
Table 13. Sanofi Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Merck Corporate Information, Head Office, and Major Competitors
Table 15. Merck Major Business
Table 16. Merck Cancer Biological Therapy Product and Solutions
Table 17. Merck Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Bayer Corporate Information, Head Office, and Major Competitors
Table 19. Bayer Major Business
Table 20. Bayer Cancer Biological Therapy Product and Solutions
Table 21. Bayer Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Roche Corporate Information, Head Office, and Major Competitors
Table 23. Roche Major Business
Table 24. Roche Cancer Biological Therapy Product and Solutions
Table 25. Roche Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Novartis International Corporate Information, Head Office, and Major Competitors
Table 27. Novartis International Major Business
Table 28. Novartis International Cancer Biological Therapy Product and Solutions
Table 29. Novartis International Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Pfizer Corporate Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Cancer Biological Therapy Product and Solutions
Table 33. Pfizer Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 35. Bristol-Myers Squibb Major Business
Table 36. Bristol-Myers Squibb Cancer Biological Therapy Product and Solutions
Table 37. Bristol-Myers Squibb Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Seattle Genetics Corporate Information, Head Office, and Major Competitors
Table 39. Seattle Genetics Major Business
Table 40. Seattle Genetics Cancer Biological Therapy Product and Solutions
Table 41. Seattle Genetics Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Amgen Corporate Information, Head Office, and Major Competitors
Table 43. Amgen Major Business
Table 44. Amgen Cancer Biological Therapy Product and Solutions
Table 45. Amgen Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Takeda Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Takeda Pharmaceuticals Major Business
Table 48. Takeda Pharmaceuticals Cancer Biological Therapy Product and Solutions
Table 49. Takeda Pharmaceuticals Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 51. GlaxoSmithKline Major Business
Table 52. GlaxoSmithKline Cancer Biological Therapy Product and Solutions
Table 53. GlaxoSmithKline Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Spectrum Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 55. Spectrum Pharmaceuticals Major Business
Table 56. Spectrum Pharmaceuticals Cancer Biological Therapy Product and Solutions
Table 57. Spectrum Pharmaceuticals Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Celgene Corporation Corporate Information, Head Office, and Major Competitors
Table 59. Celgene Corporation Major Business
Table 60. Celgene Corporation Cancer Biological Therapy Product and Solutions
Table 61. Celgene Corporation Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. AstraZeneca, Plc. Corporate Information, Head Office, and Major Competitors
Table 63. AstraZeneca, Plc. Major Business
Table 64. AstraZeneca, Plc. Cancer Biological Therapy Product and Solutions
Table 65. AstraZeneca, Plc. Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Otsuka Corporate Information, Head Office, and Major Competitors
Table 67. Otsuka Major Business
Table 68. Otsuka Cancer Biological Therapy Product and Solutions
Table 69. Otsuka Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Eisai Corporate Information, Head Office, and Major Competitors
Table 71. Eisai Major Business
Table 72. Eisai Cancer Biological Therapy Product and Solutions
Table 73. Eisai Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Abbvie Corporate Information, Head Office, and Major Competitors
Table 75. Abbvie Major Business
Table 76. Abbvie Cancer Biological Therapy Product and Solutions
Table 77. Abbvie Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Incyte Corporate Information, Head Office, and Major Competitors
Table 79. Incyte Major Business
Table 80. Incyte Cancer Biological Therapy Product and Solutions
Table 81. Incyte Cancer Biological Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Global Cancer Biological Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 83. Global Cancer Biological Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 84. Breakdown of Cancer Biological Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 85. Cancer Biological Therapy Players Head Office, Products and Services Provided
Table 86. Cancer Biological Therapy Mergers & Acquisitions in the Past Five Years
Table 87. Cancer Biological Therapy New Entrants and Expansion Plans
Table 88. Global Cancer Biological Therapy Revenue (USD Million) by Type (2017-2022)
Table 89. Global Cancer Biological Therapy Revenue Share by Type (2017-2022)
Table 90. Global Cancer Biological Therapy Revenue Forecast by Type (2023-2028)
Table 91. Global Cancer Biological Therapy Revenue by Application (2017-2022)
Table 92. Global Cancer Biological Therapy Revenue Forecast by Application (2023-2028)
Table 93. North America Cancer Biological Therapy Revenue by Type (2017-2022) & (USD Million)
Table 94. North America Cancer Biological Therapy Revenue by Type (2023-2028) & (USD Million)
Table 95. North America Cancer Biological Therapy Revenue by Application (2017-2022) & (USD Million)
Table 96. North America Cancer Biological Therapy Revenue by Application (2023-2028) & (USD Million)
Table 97. North America Cancer Biological Therapy Revenue by Country (2017-2022) & (USD Million)
Table 98. North America Cancer Biological Therapy Revenue by Country (2023-2028) & (USD Million)
Table 99. Europe Cancer Biological Therapy Revenue by Type (2017-2022) & (USD Million)
Table 100. Europe Cancer Biological Therapy Revenue by Type (2023-2028) & (USD Million)
Table 101. Europe Cancer Biological Therapy Revenue by Application (2017-2022) & (USD Million)
Table 102. Europe Cancer Biological Therapy Revenue by Application (2023-2028) & (USD Million)
Table 103. Europe Cancer Biological Therapy Revenue by Country (2017-2022) & (USD Million)
Table 104. Europe Cancer Biological Therapy Revenue by Country (2023-2028) & (USD Million)
Table 105. Asia-Pacific Cancer Biological Therapy Revenue by Type (2017-2022) & (USD Million)
Table 106. Asia-Pacific Cancer Biological Therapy Revenue by Type (2023-2028) & (USD Million)
Table 107. Asia-Pacific Cancer Biological Therapy Revenue by Application (2017-2022) & (USD Million)
Table 108. Asia-Pacific Cancer Biological Therapy Revenue by Application (2023-2028) & (USD Million)
Table 109. Asia-Pacific Cancer Biological Therapy Revenue by Region (2017-2022) & (USD Million)
Table 110. Asia-Pacific Cancer Biological Therapy Revenue by Region (2023-2028) & (USD Million)
Table 111. South America Cancer Biological Therapy Revenue by Type (2017-2022) & (USD Million)
Table 112. South America Cancer Biological Therapy Revenue by Type (2023-2028) & (USD Million)
Table 113. South America Cancer Biological Therapy Revenue by Application (2017-2022) & (USD Million)
Table 114. South America Cancer Biological Therapy Revenue by Application (2023-2028) & (USD Million)
Table 115. South America Cancer Biological Therapy Revenue by Country (2017-2022) & (USD Million)
Table 116. South America Cancer Biological Therapy Revenue by Country (2023-2028) & (USD Million)
Table 117. Middle East & Africa Cancer Biological Therapy Revenue by Type (2017-2022) & (USD Million)
Table 118. Middle East & Africa Cancer Biological Therapy Revenue by Type (2023-2028) & (USD Million)
Table 119. Middle East & Africa Cancer Biological Therapy Revenue by Application (2017-2022) & (USD Million)
Table 120. Middle East & Africa Cancer Biological Therapy Revenue by Application (2023-2028) & (USD Million)
Table 121. Middle East & Africa Cancer Biological Therapy Revenue by Country (2017-2022) & (USD Million)
Table 122. Middle East & Africa Cancer Biological Therapy Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Cancer Biological Therapy Picture
Figure 2. Global Cancer Biological Therapy Revenue Market Share by Type in 2021
Figure 3. Monoclonal Antibodies
Figure 4. Vaccines
Figure 5. Cancer Growth Blockers
Figure 6. Blood Cell Growth Factors
Figure 7. Cancer Biological Therapy Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Research & Academic Laboratories Picture
Figure 11. Pharmaceutical & Biotechnology Companies Picture
Figure 12. Global Cancer Biological Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Cancer Biological Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Cancer Biological Therapy Revenue Market Share by Region (2017-2028)
Figure 15. Global Cancer Biological Therapy Revenue Market Share by Region in 2021
Figure 16. North America Cancer Biological Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Cancer Biological Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Cancer Biological Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Cancer Biological Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Cancer Biological Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Cancer Biological Therapy Market Drivers
Figure 22. Cancer Biological Therapy Market Restraints
Figure 23. Cancer Biological Therapy Market Trends
Figure 24. ELI Lilly Recent Developments and Future Plans
Figure 25. Sanofi Recent Developments and Future Plans
Figure 26. Merck Recent Developments and Future Plans
Figure 27. Bayer Recent Developments and Future Plans
Figure 28. Roche Recent Developments and Future Plans
Figure 29. Novartis International Recent Developments and Future Plans
Figure 30. Pfizer Recent Developments and Future Plans
Figure 31. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 32. Seattle Genetics Recent Developments and Future Plans
Figure 33. Amgen Recent Developments and Future Plans
Figure 34. Takeda Pharmaceuticals Recent Developments and Future Plans
Figure 35. GlaxoSmithKline Recent Developments and Future Plans
Figure 36. Spectrum Pharmaceuticals Recent Developments and Future Plans
Figure 37. Celgene Corporation Recent Developments and Future Plans
Figure 38. AstraZeneca, Plc. Recent Developments and Future Plans
Figure 39. Otsuka Recent Developments and Future Plans
Figure 40. Eisai Recent Developments and Future Plans
Figure 41. Abbvie Recent Developments and Future Plans
Figure 42. Incyte Recent Developments and Future Plans
Figure 43. Global Cancer Biological Therapy Revenue Share by Players in 2021
Figure 44. Cancer Biological Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 45. Global Top 3 Players Cancer Biological Therapy Revenue Market Share in 2021
Figure 46. Global Top 10 Players Cancer Biological Therapy Revenue Market Share in 2021
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 48. Global Cancer Biological Therapy Revenue Share by Type in 2021
Figure 49. Global Cancer Biological Therapy Market Share Forecast by Type (2023-2028)
Figure 50. Global Cancer Biological Therapy Revenue Share by Application in 2021
Figure 51. Global Cancer Biological Therapy Market Share Forecast by Application (2023-2028)
Figure 52. North America Cancer Biological Therapy Sales Market Share by Type (2017-2028)
Figure 53. North America Cancer Biological Therapy Sales Market Share by Application (2017-2028)
Figure 54. North America Cancer Biological Therapy Revenue Market Share by Country (2017-2028)
Figure 55. United States Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Canada Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Mexico Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Europe Cancer Biological Therapy Sales Market Share by Type (2017-2028)
Figure 59. Europe Cancer Biological Therapy Sales Market Share by Application (2017-2028)
Figure 60. Europe Cancer Biological Therapy Revenue Market Share by Country (2017-2028)
Figure 61. Germany Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. France Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. United Kingdom Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Russia Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Italy Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Asia-Pacific Cancer Biological Therapy Sales Market Share by Type (2017-2028)
Figure 67. Asia-Pacific Cancer Biological Therapy Sales Market Share by Application (2017-2028)
Figure 68. Asia-Pacific Cancer Biological Therapy Revenue Market Share by Region (2017-2028)
Figure 69. China Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Japan Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South Korea Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. India Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Southeast Asia Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Australia Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South America Cancer Biological Therapy Sales Market Share by Type (2017-2028)
Figure 76. South America Cancer Biological Therapy Sales Market Share by Application (2017-2028)
Figure 77. South America Cancer Biological Therapy Revenue Market Share by Country (2017-2028)
Figure 78. Brazil Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Argentina Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Middle East and Africa Cancer Biological Therapy Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Cancer Biological Therapy Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Cancer Biological Therapy Revenue Market Share by Country (2017-2028)
Figure 83. Turkey Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Saudi Arabia Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. UAE Cancer Biological Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
